Search

This article presents a case report discussing occupational airborne allergic contact dermatitis due to 3-amino-methyl-3,5,5-trimethylcyclohexylamine. A 53-year-old man had been employed for 4 years as an impermeable-floor layer. He mixed epoxy components (Araldit GY 289 and Chemammina 931 74) with quartz powder for coating the floor. Araidit GY 289 is a stan- dard bisphenol-A-typc epoxy resin; Chemammina 93 I 74 is composed of benzyl alcohol and 3-amino- methyl-3,5,5-trirnethylcyclohexylamine.

This article presents a case of hand dermatitis due to Loctite. Loctite is the trade name of an anaerobic acrylic scalant series widely used in the mechanics industry. A man had worked for 7 years in fastening bolts in the assembly line of motorsaws. He used Loctite 221 and 270 both to seal and fasten bolts. He developed a left-hand contact dermatitis characterized by erythema, scaling and lichenification. It regressed when he stopped work for a few days and recurred with re-exposure. The dermatitis began 5 years ago, gradually changing from slight itching into dermatitis.

Coronavirus disease 2019 (COVID-19) first emerged in China in November 2019. Most governments have responded to the COVID-19 pandemic by imposing a lockdown. Some evidence suggests that a period of isolation might have led to a spike in alcohol misuse, and in the case of patients with alcohol use disorder (AUD), social isolation can favour lapse and relapse. The aim of our position paper is to provide specialists in the alcohol addiction field, in psychopharmacology, gastroenterology and in internal medicine, with appropriate tools to better manage patients with AUD and COVID-19,considering some important topics: (a) the susceptibility of AUD patients to infection; (b) the pharmacological interaction between medications used to treat AUD and to treat COVID-19; (c) the reorganization of the Centre for Alcohol Addiction Treatment for the management of AUD patients in the COVID-19 era (group activities, telemedicine, outpatients treatment, alcohol-related liver disease and liver transplantation, collecting samples); (d) AUD and SARS-CoV-2 vaccination. Telemedicine/telehealth will undoubtedly be useful/practical tools even though it remains at an elementary level; the contribution of the family and of caregivers in the management of AUD patients will play a significant role; the multidisciplinary intervention involving experts in the treatment of AUD with specialists in the treatment of COVID-19 disease will need implementation. Thus, the COVID-19 pandemic is rapidly leading addiction specialists towards a new governance scenario of AUD, which necessarily needs an in-depth reconsideration, focusing attention on a safe approach in combination with the efficacy of treatment., (© 2021 The Authors. Addiction Biology published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.)